Juli 2023, abgerufen am 15
The most commonly reported include gastrointestinal disturbances such as nausea, diarrhoea, abdominal discomfort, and loss of appetite
95% CI, 0.68-0.98), and TZD (HR, 0.82
Frontiers in Endocrinology (Lausanne), 14, 10957531095753
Common ones may include: Mild nausea Digestive changes Temporary fatigue More serious effects are rare but possible, which is why its essential to have physician oversight throughout treatment
Patients who suffer from an underlying renal impairment are at a higher risk of kidney damage in case they decide to treat with Semaglutide